Origins of tremor
RJ Elble - The Lancet, 2000 - thelancet.com
RJ Elble
The Lancet, 2000•thelancet.com7 Selvais PL, Donckier JE, Robert A, et al. Cardiac natriuretic peptides for diagnosis and risk
stratification in heart failure: influences of left ventricular dysfunction and coronary artery
disease on cardiac hormonal activation. Eur J Clin Invest 1998; 28: 636–42. 8 Tsutamoto T,
Wada A, Maeda K, et al. Plasma brain natriuretic peptide level as a biochemical marker of
morbidity and mortality in patients with asymptomatic or minimally symptomatic left
ventricular dysfunction: comparison with plasma angiotensin II and endothelin-1.
stratification in heart failure: influences of left ventricular dysfunction and coronary artery
disease on cardiac hormonal activation. Eur J Clin Invest 1998; 28: 636–42. 8 Tsutamoto T,
Wada A, Maeda K, et al. Plasma brain natriuretic peptide level as a biochemical marker of
morbidity and mortality in patients with asymptomatic or minimally symptomatic left
ventricular dysfunction: comparison with plasma angiotensin II and endothelin-1.
7 Selvais PL, Donckier JE, Robert A, et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. Eur J Clin Invest 1998; 28: 636–42. 8 Tsutamoto T, Wada A, Maeda K, et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction: comparison with plasma angiotensin II and endothelin-1.
thelancet.com
